Search research articles
Contact Us
Filters
Showing results (751-760 of 778) with videos related to
Page
of 78
Sort By:
The Journal of Physical Chemistry. A
|
October 19, 2016
Direct Measurements of Unimolecular and Bimolecular Reaction Kinetics of the Criegee Intermediate (CH<sub>3</sub>)<sub>2</sub>COO
Rabi Chhantyal-Pun, Oliver Welz, John D Savee, et al.
Nature Genetics
|
December 20, 2017
Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis
Arjan Pol, G Herma Renkema, Albert Tangerman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 5, 2022
Perspectives on Cognitive Phenotypes and Models of Vascular Disease
Selen C Muratoglu, Marc F Charette, Zorina S Galis, et al.
JAMA Pediatrics
|
May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
Mao Hu, Hui Lee Wong, Yuhui Feng, et al.
Plos One
|
November 24, 2025
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
Shelby S Fisher, Arnstein Lindaas, Stella G Muthuri, et al.
Pharmacoepidemiology and Drug Safety
|
May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United States
Patricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
Vaccine
|
August 22, 2025
Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analyses
Patricia C Lloyd, Gyanada Acharya, Henu Zhao, et al.
Vaccine
|
February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020
Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Vaccine
|
October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
Patricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open
|
April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years
Mao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Page
of 78
Search research articles
Search
Showing results (751-760 of 778) with videos related to
Sort By:
Page
of 78
The Journal of Physical Chemistry. A
|
October 19, 2016
Direct Measurements of Unimolecular and Bimolecular Reaction Kinetics of the Criegee Intermediate (CH<sub>3</sub>)<sub>2</sub>COO
Rabi Chhantyal-Pun, Oliver Welz, John D Savee, et al.
Nature Genetics
|
December 20, 2017
Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis
Arjan Pol, G Herma Renkema, Albert Tangerman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 5, 2022
Perspectives on Cognitive Phenotypes and Models of Vascular Disease
Selen C Muratoglu, Marc F Charette, Zorina S Galis, et al.
JAMA Pediatrics
|
May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
Mao Hu, Hui Lee Wong, Yuhui Feng, et al.
Plos One
|
November 24, 2025
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
Shelby S Fisher, Arnstein Lindaas, Stella G Muthuri, et al.
Pharmacoepidemiology and Drug Safety
|
May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United States
Patricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
Vaccine
|
August 22, 2025
Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analyses
Patricia C Lloyd, Gyanada Acharya, Henu Zhao, et al.
Vaccine
|
February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020
Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Vaccine
|
October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
Patricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open
|
April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years
Mao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Page
of 78